Home
>
Reference Standards>Chemical Reagents> 4-[1-Chloro-2-(methylamino)ethyl]phenyl Acetate Hydrochloride
For research use only. Not for therapeutic Use.
CpdA is a non-steroidal selective glucocorticoid receptor modulator. It is an aziridine precursor that can infiltrate cells and is translocated to the nucleus. It inhibits glucocorticoid receptor dimerization, which prevents transcription of gene targets such as NF-κB and subsequent cytokines through transrepression. Studies have shown contradictory results for binding affinity of CpdA compared with dexamethasone (Item No. <span class=/itemid/>11015</span>) that were either higher (4-fold, IC<sub>50</sub> = 6.4 nM and 25.9 nM, respectively, in L929sA cells) or lower (63-fold, K<sub>d</sub> = 81.8 nM and 1.29 nM, respectively, in BWTG3 cells) in whole cell binding assays.
Catalog Number | M134673 |
CAS Number | 14593-25-0 |
Synonyms | Compound A |
Molecular Formula | C11H15Cl2NO2 |
Purity | ≥95% |
Storage | -20°C |
IUPAC Name | [4-[1-chloro-2-(methylamino)ethyl]phenyl] acetate;hydrochloride |
InChI | InChI=1S/C11H14ClNO2.ClH/c1-8(14)15-10-5-3-9(4-6-10)11(12)7-13-2;/h3-6,11,13H,7H2,1-2H3;1H |
InChIKey | WKMYTPCPAWZWII-UHFFFAOYSA-N |
SMILES | CC(=O)OC1=CC=C(C=C1)C(CNC)Cl.Cl |